Want to join the conversation?
$CTRE increased its 2016 normalized FFO per share guidance to range of $1.06-1.08 from previous forecast of $1.05-1.07. The increased guidance assumes no new acquisitions beyond those made and announced to date. $CTRE lowered its normalized FAD per share outlook to range of $1.14-1.16 from prior estimate of $1.15-1.17.
$YHOO is reporting today after market close. Nobody cares about this stock.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.